FALL 2018 | VOL. 15, ISSUE 2 HeadsUp! News from the UCSF Department of Otolaryngology – Head and Neck Surgery

Also in This Issue Jennifer Grandis, MD 2 Message from the Chair 2 UCSF Offers OHNS Services Jennifer Grandis, MD, Takes Aim at at New Berkeley Facility Human Papilloma Virus 4 Annual Roger Boles Lecture Addresses HPV in Oral Cancer Jennifer Grandis, MD, will be pursuing high risk, high gain research 4 Dr. Grandis is named the Werbe on human papilloma virus, or HPV, with the support of a seven-year Distinguished Professor Outstanding Investigator Award (an R35 grant) from the National 5 Department Welcomes Four Cancer Institute. New Faculty Historically, most cancers that arise in the mouth or throat are associated with 6 Jun Lab Moves to the Mission exposure to tobacco. But in the last decade there has been an explosion in the Bay Campus number of cancers that arise in the throat, due to infection with HPV. 7 New Residents and Fellows “We know the HPV virus causes cervical cancer and also cancers in some other 8 Upcoming Events parts of the body. Now, increasingly, HPV is also causing cancers of the throat – so much so that this year there was a paper indicating that for the very first time, the number of throat cancers caused by HPV in men surpassed the numbers of cervical cancers in women. And it makes sense because the virus is ubiquitous. All humans are exposed to it once they are sexually active,” said Dr. Grandis, who is the Robert K. Werbe Distinguished Professor in Head and Neck Cancer in the Department of Otolaryngology – Head and Neck Surgery. Continued on page 3

Inspired by our patients, driven by our passion, energized by innovation Message from the Chair Berkeley Outpatient Center A Time of Honors, a New UCSF Offers OHNS Services Facility, and New Faculty at New Berkeley Facility new medical center in the heart of Berkeley, , This issue of Heads Up! gives me reason to feel proud now includes the full range of clinical services offered of our Department of Otolaryngology – Head and by the UCSF Department of Otolaryngology – Head Neck Surgery! A and Neck Surgery. The lead article on page 1 tells of Jennifer Grandis’s The Berkeley Outpatient Center, which is jointly operated by R35 Outstanding Investigator award from the NIH, which UCSF Health and , is located at 3100 San is a career honor that few can hope to attain. As you will Pablo Avenue in Berkeley. The center opened in June 2018, read on page 4, Jenny also was honored with a and in September, Otolaryngology – Head and Neck Surgery distinguished professorship, having joined other specialty and primary health care services already been named the Robert K. Werbe at the new site. Distinguished Professor in Head and OHNS services available at the Berkeley Outpatient Center Neck Cancer. When you see her include: next time, please offer congratula- tions on this amazing and highly ■■ General Otolaryngology deserved recognition. ■■ Facial Plastics and Reconstructive Surgery In September our department ■■ Rhinology/Sinus began providing services at our ■■ Sleep Medicine and Surgery newest location at the Berkeley Outpatient Center, which is UCSF’s ■■ Head and Neck Cancer and Endocrine Surgery first footprint in the East Bay. It is ■■ Salivary Gland Surgery a fantastic facility that will be staffed In addition to surgical specialists, there is a full complement by a number of faculty, but anchored of audiologists and speech and swallow therapists to help the by Anna Butrymowicz, MD, who center cover the full breadth of otolaryngologic complaints. recently joined us from New York. Anna Butrymowicz, MD, is the lead otolaryngologist at the Andrew H. Murr, MD We are very excited to introduce Berkeley Outpatient Center. She is an experienced her to you. otolaryngologist who came to UCSF in August after serving as This issue of Heads Up! also introduces three other a practicing otolaryngologist at Jacobi Medical Center in the new faculty. Neil Bhola, PhD joined the department in Bronx, New York (see her profile on page 5). February as an assistant professor. He is investigating the “Dr. Butrymowicz has been instrumental in establishing the mechanistic and immunotherapeutic implications of department’s footprint in the East Bay,” said Department Chair chromatin regulation in drug resistant models of head and Andrew Murr. “She and our other UCSF Otolaryngology-Head neck squamous cell carcinoma and non-small cell lung and Neck Surgery experts offer the full range of our services cancer as a member of the Head and Neck Cancer in a local setting for East Bay patients.” Laboratory. Andrea Park, MD joined the microvascular “We are focused on the community,” Dr. Butrymowicz team as a reconstructive surgeon. Dr. Park will work out said. “The Berkeley Outpatient Center offers high quality of all sites, but her main office will be the Facial Plastic otolaryngology-head and neck surgery options to patients Surgery Office on the Mount Zion Campus. And Matthew in the East Bay with the same empathy, attention to detail, Spitzer, PhD, joined the department as an assistant and cutting-edge techniques that have made UCSF a professor who will be concentrating on advancing household name.” translational care for head and neck cancer patients. The new center is located within easy access of the I-80 Finally, UCSF Medical Center has been named Best in freeway and has ample validated parking onsite. There are the West by US News with a #6 ranking. The Department numerous public transportation options nearby as well. n of Otolaryngology – Head and Neck Surgery moved up to #7 in the US News ranks. And we remain #1 in NIH funding for an OHNS department as tallied by the Blue Ridge Institute for Medical Research. I’d like to close by saying that I hope to see you soon at one of our CME courses in or Hawaii. Warmly, Andrew H. Murr, MD, FACS Chairman, Professor of Clinical Otolaryngology – Head and Neck Surgery, Department of Otolaryngology – Head and Neck Surgery Berkeley Outpatient Center

2 HeadsUp! Fall 2018 Taking Aim at HPV Continued from page 1 Vaccination is key It is likely that most of these HPV-related throat cancers can be prevented by FDA-approved vaccines. The FDA recently approved the HPV vaccine for adults between the ages of 27 and 45. The FDA previously approved the HPV vaccine for people age 9 to 26. It is critical that children be vaccinated before they are exposed to the virus, and while vaccination against HPV appears to be rising among girls in most of the United States, boys are The FDA recently approved the HPV vaccine less commonly vaccinated. Legislation for adults between the ages of 27 and 45. has been enacted in some states to facilitate or mandate HPV vaccination, but in most states parents can choose “Until most of our whether to vaccinate their children. “Unless you have been vaccinated population is vaccinated against the virus, you are at risk of against this cancer-causing getting the cancers associated with the virus. Until most of our population is virus prior to exposure, vaccinated against this cancer-causing we are going to continue to virus prior to exposure, we are going to continue to see an increasing number see an increasing number of of cancer cells and exploit them as of head and neck cancers that are head and neck cancers that therapeutic targets. To identify caused by HPV. How best to treat these vulnerabilities, scientists perform genetic cancers is the focus of my grant,” are caused by HPV. How “loss-of-function” and “gain-of-function” Dr. Grandis explains. studies to better understand the roles of “We know about smoking. We know best to treat these cancers is specific genes in cancer cells. OHNS to tell people not to smoke, and we the focus of my grant.” researchers are employing technologies know to help people to stop smoking – that are relatively new and that were — Jennifer Grandis, MD it is an addiction. But what we really largely invented at UCSF and at UC can’t do right now is protect the people Berkeley. These technologies include the who have not been vaccinated against therapeutic targets in patients’ tumors. genetic engineering system called HPV. And we understand that for the This will allow doctors to deliver more Clustered Regularly Interspaced Short next 30 to 40 years – because it takes a effective and less toxic therapy. Palindromic Repeats/CRISPR- long time for the virus to cause the Members of Dr. Grandis’s research Associated protein 9 (CRISPR/Cas9), as cancer – we are going to continue to team and others have already done well as protein-protein interaction see an increasing number of throat plenty of work towards understanding mapping using affinity purification mass cancers caused by this virus,” she adds. the mutations that characterize HPV spectrometry. head and neck cancer. They can Daniel Johnson, PhD, a professor in Focusing on genetics identify which mutations occur in which OHNS, is the project co-director with Dr. Grandis says that people who have cancers, and there is a list of “activating Dr. Grandis. Their research team head and neck cancer caused by mutations” that turn things on, and includes Mi-Ok Kim, PhD, a professor in HPV do better than those with head “inactivating mutations” that turn Epidemiology and Biostatistics, Danielle and neck cancer from other causes. things off. Swaney, PhD, an assistant professor in It is a different disease, with a better “We know which mutations are Cellular and Molecular Pharmacology, prognosis, because there are fewer more common in HPV head and neck and Neil Bhola, an assistant professor genetic mutations to deal with. cancers, but what we really don’t know in OHNS. “However, we still treat patients with is how to leverage that information for The R35 grant will allow Dr. Grandis HPV-associated head and neck cancer therapy,” Dr. Grandis says. to collaborate with scientists in the lab with toxic treatments including of Nevan J. Krogan, PhD, in the chemotherapy and radiation,” says Exploiting cells as therapeutic Department of Cellular and Molecular Dr. Grandis, whose research aims to targets Pharmacology. They will collectively take advantage of the vast amount of A central goal of research for targeted perform synthetic genetic interaction genetic information now available about cancer therapy, or precision oncology, screening and combine the results with these cancers to identify optimum is to reveal the intrinsic vulnerabilities Continued on next page

HeadsUp! Fall 2018 3 Pursuing High Risk, High Gain Research Continued from previous page what’s known as a protein-protein interaction map in cell culture models. Dr. Grandis will explore whether patients with HPV head and neck cancer who have certain mutations are extremely sensitive to specific drugs or combinations of drugs. Ultimately, this could lead to clinical trials involving patients whose tumors test positive for HPV head and neck cancer. Using the UCSF 500 “Using a new molecular diagnostic test called the UCSF 500, we can determine the mutational profile of a patient’s tumor, and then we can assign them to the treatment that we believe would be best for them. That’s the ultimate goal,” Dr. Grandis is named she explains. the Werbe Distinguished The NCI says that its Outstanding Investigator Award “supports investigators Professor with outstanding records of productivity in cancer research by providing ndrew Murr, MD, chair of the extended funding stability and encouraging investigators to continue or embark Department of Otolaryngology – on projects of unusual potential in cancer research. The award provides up to A Head and Neck Surgery, $600,000 in direct costs per year for 7 years, allowing substantial time for funded announced that Jennifer Grandis, MD, investigators to take greater risks and be more adventurous in their research.” has been appointed to the Robert K. “This grant provides our team with durable resources so that we will be able Werbe Distinguished Professorship. to focus on the research without being distracted by the administrative obstacles “Distinguished professorships are that generally accompany efforts to secure lab funding,” Dr. Grandis says. n among the highest honors that can be bestowed in the system, and this professorship is a Annual Roger Boles Lecture Addresses HPV recognition of Jennifer’s lifelong pursuit in Oral Cancer of investigation,” Dr. Murr said. “This appointment recognizes her heodoros (Ted) Teknos, MD, a leading authority on head and neck phenomenal contribution to the cancers, discussed human papilloma virus (HPV) in head and neck cancer advancement of our understanding of Tat this year’s Roger Boles, MD, Lecture on September 20 at Pottruck the mechanisms underlying head and Auditorium, Rock Hall on the Mission Bay campus. neck cancer,” Dr. Murr continued. Dr. Teknos is the president and scientific director Dr. Grandis came to UCSF in January for the Seidman Cancer Center at University 2015 as an American Cancer Society Cleveland Medical Center and is the deputy Professor, setting up the Head and Neck director of the Case Comprehensive Cancer Center. Cancer Laboratory at UCSF with Patrick He is a clinical professor in the Department of Ha, MD, and Daniel Johnson, PhD. Otolaryngology – Head and Neck Surgery at the She earned her MD at the University Case Western Reserve University School of Medicine. of Pittsburgh School of Medicine, The Boles Lecture series is dedicated to the and she completed a residency in memory of Roger Boles, MD, the former Chair of Otolaryngology – Head and Neck UCSF’s Department of Otolaryngology – Head and Surgery and a research fellowship in Neck Surgery. Dr. Boles served as department chair Infectious Disease there. for 15 years, from 1974-1989. He was an expert Theodoros (Ted) Teknos, MD After accepting a faculty position at physician and surgeon, a dedicated teacher, and an extraordinary leader. The the University of Pittsburgh, she rose Roger Boles, MD Endowed Lecturer series serves to continue UCSF’s dedication through the ranks to become a full professor, practicing as a general to research, education, and service in Dr. Boles’s name. n otolaryngologist as well as a research scientist focused on head and neck cancer investigations. Recently her scientific contributions were recognized by the NIH with an R-35 grant award (see story on page 1). As the Werbe Distinguished Professor, Dr. Grandis will continue her work to unravel the biologic complexity of head and neck cancer and to identify improved therapies for head and neck cancer patients. n Human Papilloma Virus Cells

4 HeadsUp! Fall 2018 Department Welcomes Four New Faculty

Neil Bhola, PhD teams. “She will be a part of the head and neck reconstructive Dr. Bhola joined the Department of team and will also help to build our practice in aesthetic facial Otolaryngology-Head and Neck Surgery plastic surgery,” said Department Chair Andrew Murr. “She will in February as an assistant professor. participate in facial nerve rehabilitation surgery for those with He is part of the research team working facial paralysis. She will also be on the team that concentrates closely with Drs. Jennifer Grandis, on gender reassignment surgery for our patients undergoing Patrick Ha and Daniel Johnson in the gender transition,” Dr. Murr added. OHNS Head and Neck Cancer Lab Dr. Park attended the University of Iowa Carver College of where he is utilizing novel methodology Medicine, where she obtained her medical degree. There, she to understand the chromatin landscape won the Berens-Krehbiel Research Scholarship and received utilized by cancer cells to escape both Research and Service Distinctions upon graduation. Her drug targeting. OHNS residency was completed at Washington University Dr. Bhola completed his PhD in molecular pharmacology in St Louis, where she was the recipient of the Michael at the University of Pittsburgh, and his post-doctoral Paparella Research Award and the American Laryngological research was in hematology-oncology at Vanderbilt University. Association Resident Research Award, both in 2015. An author on over 20 peer-reviewed publications. Dr. Bhola She served as a T32 Fellow during her residency. In 2017, came to UCSF in 2015 as an assistant professional Dr. Park was inducted into the AOA. Dr. Park will work out of otolaryngology researcher. all sites, but her main office will be the Facial Plastic Surgery Office on the Mount Zion Campus. She will also provide Anna Butrymowicz, MD service at the new Berkeley Outpatient Center. Anna Butrymowicz, MD, joined the department as an assistant professor Matthew Spitzer, PhD in August 2018. While her principal In July 2018, Matthew Spitzer, role is to open and run the depart- PhD, joined the Department of ment’s newest location at the Berkeley Otolaryngology – Head and Neck Outpatient Center (see story page 2), Surgery as an assistant professor. she will also be part of the general In announcing the appointment, otolaryngology-head and neck Department Chair Andrew Murr surgery group practice headquartered noted that “Matthew will be a at the ambulatory site on the Mount major contributor to advancing Zion campus. translational care for head and neck Dr. Butrymowicz earned her MD in 2011 from Drexel cancer patients.” University College of Medicine. She was chief resident during “Matt works on HPV as it relates to squamous cell her residency in otolaryngology-head and neck surgery at carcinoma, and he has partnered with Jennifer Grandis, Dan Albany Medical Center in New York. Johnson, and Patrick Ha on neoadjuvant During residency, she received both an American Academy clinical trials of immunotherapy in head and neck squamous of Otolaryngology-Head and Neck Surgery Resident carcinoma,” said Dr. Murr. “He also is investigating the impact Leadership Grant and a Humanitarian Grant. Following of obesity and high fat diet on the immune response to completion of her residency, Dr. Butrymowicz accepted a cancer and on the impact of metastasis on the immune position as an attending physician with Jacobi Medical Center system and its effect on immunotherapy. Matt is an expert in (part of the Albert Einstein System) in the Bronx, New York. CyTOF technology and will be helping to further establish and There, she served as a general otolaryngologist with a special improve a core facility with CyTOF capability at UCSF.” interest in the areas of sinus surgery and rhinology. After earning a doctorate in immunology at Stanford University, Dr. Spitzer completed a postdoctoral fellowship Andrea Park, MD at Stanford under Drs. Gary Nolan and Edgar Engleman in Andrea Park, MD, joined the the departments of Microbiology & Immunology, Pathology, Department of Otolaryngology – and Medicine. Head and Neck Surgery in September Dr. Spitzer came to UCSF in 2016 as a Sandler and Parker 2018 as an assistant professor in the Fellow, where he pursued work in tumor immunology and Division of Facial Plastic and systems biology working in the Department of Microbiology Reconstructive Surgery. and Immunology under the direction of Lewis Lanier, PhD. In this capacity she will work with Dr. Spitzer was selected for Chan Zuckerberg resource Division Chief Daniel Knott, MD, and support during his recruitment. “For this resource we owe Rahul Seth, MD, as well as the entire thanks to Dr. Lanier, Dean Dr. Talmadge King, and Chancellor skull base and head and neck oncology Dr. Sam Hawgood” said Dr. Murr. n

HeadsUp! Fall 2018 5 Fostering Collaboration Jun Lab Moves to the Mission Bay Campus

brand new research building in whose research topic is “Spatio- and facilities for the use of animal the heart of UCSF’s Mission Bay mechanical regulation of T cell specimens. The site also hosts multiple A campus is the new location for receptor signaling.” scientific seminars of interest to the laboratory of Young-Wook Jun, PhD, ■■ Yuetao Zhao, PhD, a postdoctoral researchers.” associate professor and director of the specialist whose research topic is “Another advantage of the location is Nano-Probing Single Biomolecule “Microtissue pressure sensor.” that it will facilitate the recruitment of Dynamics Laboratory in the Department graduate students and postdoctoral ■■ Gicheol Park, MD, a visiting scholar, of Otolaryngology – Head and Neck researchers” said Dr. Jun. “Most of the whose research topic is “Cell surface Surgery. graduate programs – including the dynamics of cadherin junctional The UCSF Helen Diller Family Chemistry and Chemical Biology (CCB) complexes.” Cancer Research Building is the lab’s Graduate Program, Bioengineering, new home. The building has space ■■ Li Gao, PhD, a visiting scholar, whose Tetrad, and the Integrative Program in for up to 400 scientists and contains research topic is “Notch structure and Quantitative Biology (iPQB) – are located 33 laboratories. It combines basic function.” at Mission Bay, with student classes science, clinical research, epidemiology ■■ Heekyung Jeong, a visiting graduate held at that location as well. I anticipate and cancer control and patient care in student with a B.S. in Chemistry/ easier student recruitment to my lab.” one facility. Biochemistry whose research topic Dr. Jun envisioned “a unique “The Diller Family Cancer facility is “Plasmonic systems to probe research program at UCSF that provides a unique research environment single molecule rotational and develops ‘translational’ and to foster teamwork among basic translation dynamics.” ‘transformative’ nanotechnology tools to scientists and physician scientists,” Dr. Jun noted the benefits of the address highly important biomedical Dr. Jun said. “I envision many new more interactive and supportive questions to deepen our understanding exciting collaborations within the Cancer research environment at the new site: of complex developmental, physio- Center, the Mission Bay campus, and “There are very well-established core logical, and pathological processes with the . For example, in facilities available to scientists including a goal to contribute to public health. just the first two months since the move, the Laboratory for Cell Analysis (LCA), He noted that: “Both the Helen Diller we established new collaborations with which provides cytometric, microscopic, Cancer Research Building and the Drs. Todd McDevitt in Bioengineering and genomic support; the Nikon Imaging Mission Bay campus offer a dynamic and Shawn Douglas in Cellular Center, which provides light microscopy research environment that will facilitate Molecular Pharmacology. Also, our instrumentation services; the UCSF my lab’s work.” existing collaborators, Drs. Zev Gartner Functional Genomics Core; the Center The Jun Lab moved from its previous and Ron Vale are located at Mission for Advanced Technology (CAT); location at 2340 Sutter Street near the Bay. Being in the heart of Mission Bay Mount Zion campus in July 2018. n will strengthen the group effort and To learn more about the Jun Lab, performance,” Dr. Jun continued. visit http://junlab.ucsf.edu. The Jun Lab focuses on investigating nanocrystal molecules, including the Young-Wook Jun, PhD fabrication, surface chemistry, and scaling laws of magnetic, plasmonic, and charge coupling, as well as their behaviors in cells. In addition to Dr. Jun, the team includes: ■■ Christopher Boone, a junior specialist with a B.S. degree in Biology, whose research topic is “Identification of mechanotransduction mechanisms in touch sensation.” ■■ Hyun Jung Lee, PhD, a postdoctoral specialist whose research topic is “Axonal specification of neuron cells.” ■■ Woon-Ryoung Kim, PhD, an associate specialist, whose research topic is “Synaptogenesis.” ■■ Minsuk Kwak, PhD, a Shurl and Kay UCSF Helen Diller Family Cancer Research Building Curci LSRF Postdoctoral Fellow,

6 HeadsUp! Fall 2018 Welcome to the Department INCOMING FELLOWS Zachary C. Fridirici, MD New Residents and Fellows Dr. Fridirici joined the department in July as a Facial Plastic and Reconstructive Surgery RESIDENCY CLASS OF 2023 Fellow. He earned his medical degree, cum Kara D. Brodie, MD laude at the Loyola University of Chicago, Dr. Brodie received a Masters of Philosophy Stritch School of Medicine in 2013, and he in Public Health from the University of completed his residency in Otolaryngology Cambridge, in Cambridge, England. In 2018, at the same institution. During his time at she received her Medical Degree from the Stritch School of Medicine, Dr. Fridirici was UC Davis School of Medicine, where she elected to Alpha Omega Alpha. He also served as vice- was named a member of the Alpha Omega president of the Otolaryngology Interest Group and as student Alpha Honor Medical Society and the Gold coordinator of the Surgery Teaching Elective. He is the CEO Humanism Honor Society. She was the and Founder of MedDocLive, LLC, an electronic health recipient of an Alpha Omega Alpha Medical Student Service records consulting firm. Leadership Award and received matching funds from UC Davis Andrée-Anne Leclerc, MD for the development of the Partners in Transforming Community Dr. Leclerc joined the department as a Health Program, implemented fall 2016. Laryngology Fellow in July 2018. She Abel P. David, MD earned her medical degree from the In 2018, Dr. David received his Medical University of Montreal, Montréal, Québec, Degree from the University of Virginia Canada in 2012 after receiving her Master’s School of Medicine in Charlottesville, Degree in Biomedical Sciences, Research Virginia. He was the leader of the in Medical Education from the same Otolaryngology – Head and Neck Surgery university. Dr. Leclerc received her post- Interest Group there, and he was involved in doctoral specialization in and Head Neck research projects focused on insulin-like Surgery from the University of Montreal in 2017. She received growth factor receptor (IGFR) pathway in her Certification in Otolaryngology and Head and Neck head and neck squamous cell carcinoma tumor progression Surgery (FRCSC) from the Royal College of Physicians and and therapeutics as well as a project focused on determining Surgeons of Canada in 2017. the safety and use of proton pump inhibitors (PPIs) in David W. Schoppy, MD, PhD laryngopharyngeal reflux. After completing a residency in Gaelen B. Stanford-Moore, MD Otolaryngology – Head and Neck Surgery Dr. Stanford-Moore received a Master of at Stanford University, Dr. Schoppy joined Philosophy degree in Epidemiology from the department as the Bryan Hemming the Department of Public Health at the Endowed Fellow in July 2018. He earned University of Cambridge, United Kingdom both his Medical and Doctoral degrees before earning her medical degree from from the University of Pennsylvania, with UCSF in 2018. Dr. Stanford-Moore was the an emphasis in Cancer Biology, in 2013. clinic leader at the Clínica Martín-Baró He received the University of Pennsylvania’s Rose Meadow Student-Run Free Clinic in San Francisco, Levinson Laboratory Research Award and an NRSA F30 grant where she led a project with the California Department of from the National Institute on Aging. His publications include Public Health to secure free HIV-rapid tests for the clinic. first-author papers inNature Genetics, JCI, and JAMA She spent time during medical school in England and Kenya Otolaryngology–Head and Neck Surgery. following her passion about global health and global access to safe surgery. She has also co-authored several manuscripts Tammy Jill Wang, MD on HIV treatment and prevention. Dr. Wang joined the department as the Pediatric Otolaryngology fellow in July Richie Tian Ran Zhu, MD 2018. After earning her medical degree In 2013, Dr. Zhu completed a post- from Case Western Reserve University baccalaureate degree as a research fellow School of Medicine in Cleveland, Ohio with with the National Institutes of Health an Alpha Omega Alpha distinction, Dr. Vaccine Research Center in Bethesda, Wang completed a four-year residency in Maryland. In 2018, Dr. Zhu completed his Otolaryngology at the University Hospitals medical degree at the Warren Alpert Cleveland Medical Center. She has designed and implemented Medical School of Brown University in workshops and clinical simulations to improve basic surgery Providence, Rhode Island. There, his skills for the Otolaryngology Boot Camp at the University leadership roles included service as an anatomy student Hospitals and has also led workshops and has guided clinical course leader. During 2017-18 he performed research with teaching at the Student-Run Free Clinic of Case Western Drs. Jennifer Grandis, Daniel Johnson, and Patrick Ha at UCSF. Reserve University. n

HeadsUp! Fall 2018 7 Nonprofit Org. U.S. Postage PAID San Francisco, CA Permit No. 8285

Otolaryngology | Head and Neck Surgery 2233 Post Street, UCSF Box 1225 San Francisco, CA 94115

ADDRESS SERVICE REQUESTED

Upcoming Events

Techniques in Sialendoscopy and Salivary Duct Surgery HeadsUp! November 29, 2018 FALL 2018 | VOL. 15, ISSUE 2 JW Marriott, San Francisco, CA Department Chairman, Editor-in-Chief: Technology, Innovation, and Personalized Care Andrew H. Murr, MD in Head and Neck Cancer Event and Communications Manager: November 30–December 1, 2018 Katherine Murphy JW Marriott, San Francisco, CA Web and Media Specialist: Clinton Louie Design: Laura Myers Design The Robert A. Schindler, MD Lectureship Photography: Elisabeth Fall, Marco Sanchez December 6, 2018, 5:00–6:00 pm © 2018 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Speaker: Clough Shelton, MD, University of Utah UCSF Mission Bay, Pottruck Auditorium, Rock Hall Contact Us General Otolaryngology The 25th Annual Advances in Diagnosis and Treatment Pediatric Otolaryngology – HNS of Sleep Apnea and Snoring Otology, Neurotology and Skull Base Surgery February 15–17, 2019 Rhinology and Sinus Surgery Disney’s Grand Floridian Resort & Spa, Lake Buena Vista, FL Sleep Surgery 415/353-2757 Pacific Rim Otolaryngology – Head and Neck Surgery Update Cochlear Implant Center 415/353-2464 Conference Facial Plastic and Aesthetic Surgery Practice February 16–19, 2019 UCSF Medical Center Moana Surfrider Hotel, Waikiki Beach, Honolulu, HI 415/353-9500 HNS – Facial Plastic and Post-Oncologic Laryngeal Endostroboscopy and FEES: Performance and Interpretation Reconstructive Surgery, UCSF Helen Diller April 3–5, 2019 Family Comprehensive Cancer Center UCSF Voice and Swallowing Center, San Francisco, CA 415/885-7528 17th Annual Resident Research Symposium Head and Neck Surgery and Oncology Head and Neck Endocrine Surgery June 7, 2019, 1:00–5:00 pm Salivary Gland Center UCSF Mission Bay 415/885-7528 The Francis A. Sooy, MD Lectureship Balance and Falls Center 415/353-2101 June 8, 2019, 8:00–11:30 am Voice and Swallowing Center 415/885-7700 Speaker: Neal D. Futran, MD, University of Washington Audiology 415/353-2101 UCSF Mission Bay To support the Department of Otolaryngology – Head and Neck Surgery, For further information about CME courses, please go to http://cme.ucsf.edu. please contact Director of Development For information on Ground Rounds and departmental events, please visit Darrell Young at 415/502-8389 or http://ohns.ucsf.edu or contact Joanna Times at [email protected]. [email protected].

News from the UCSF Department of Otolaryngology – Head and Neck Surgery | http://ohns.ucsf.edu